Loïc Raoux1, David Moszkowicz2,3,4, Karina Vychnevskaia1, Tigran Poghosyan1,5, Alain Beauchet6, Sylvain Clauser5,7, Marion Bretault5,8, Sébastien Czernichow5,8, Claire Carette8, Jean-Luc Bouillot1,5. 1. Department of Digestive, Oncologic and Metabolic Surgery, Ambroise Paré Hospital, Boulogne-Billancourt, France. 2. Department of Digestive, Oncologic and Metabolic Surgery, Ambroise Paré Hospital, Boulogne-Billancourt, France. david.moszkowicz@aphp.fr. 3. Service de Chirurgie Digestive, Oncologique et Métabolique, Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92100, Boulogne-Billancourt, France. david.moszkowicz@aphp.fr. 4. Versailles St-Quentin-en-Yvelines University, 78180, Montigny-Le-Bretonneux, France. david.moszkowicz@aphp.fr. 5. Versailles St-Quentin-en-Yvelines University, 78180, Montigny-Le-Bretonneux, France. 6. Department of Biostatistics, Ambroise Paré Hospital, Boulogne-Billancourt, France. 7. Department of Hematology, Ambroise Paré Hospital, Boulogne-Billancourt, France. 8. Department of Nutrition, Ambroise Paré Hospital, Boulogne-Billancourt, France.
Abstract
BACKGROUND: Abdominal obesity is strongly correlated with cardiovascular risk and associated with platelet hyperactivity. This hyperactivity is associated with an increase in mean platelet volume (MPV). Few data are available about changes in platelet counts and MPV in obese patients after bariatric surgery (BS). The purpose of this study was to describe quantitative and qualitative changes in the platelet lineage after BS. METHODS: One hundred twenty-eight consecutive patients were included. The mean age was 43 ± 12 years, 77 % of patients were female, and the mean preoperative BMI was 44 ± 6 kg/m2. Ninety patients (71 %) had a Roux-en-Y gastric bypass (RYGBP), and 38 (29 %) had a sleeve gastrectomy (SG). Patients were evaluated preoperatively, and postoperative follow-up was performed at 3, 6, and 12 months. The postoperative evaluation included blood samples for full blood count (FBC), including measure of mean platelet volume (MPV). RESULTS: At the 12-month follow-up, the reduction in preoperative weight was 29 ± 9 %. We showed a significant decrease in platelet count (245 ± 62 vs. 234 ± 54 G/L; p = 0.0015) found in parallel with a non-significant decrease in MPV (9.27 ± 1.1 vs. 9.22 ± 1.05; p = 0.34). With regard to the intervention type, SG caused a more significant decrease in platelet count than RYGBP (p = 0.02). There was no significant difference in MPV variations between the two groups (p = 0.08). CONCLUSIONS: Our results suggest that BS has a positive impact on platelet metabolism, possibly mediated by weight loss. These data need to be confirmed to understand the multifactorial benefits of BS on cardiovascular risk in obese patients.
BACKGROUND:Abdominal obesity is strongly correlated with cardiovascular risk and associated with platelet hyperactivity. This hyperactivity is associated with an increase in mean platelet volume (MPV). Few data are available about changes in platelet counts and MPV in obesepatients after bariatric surgery (BS). The purpose of this study was to describe quantitative and qualitative changes in the platelet lineage after BS. METHODS: One hundred twenty-eight consecutive patients were included. The mean age was 43 ± 12 years, 77 % of patients were female, and the mean preoperative BMI was 44 ± 6 kg/m2. Ninety patients (71 %) had a Roux-en-Y gastric bypass (RYGBP), and 38 (29 %) had a sleeve gastrectomy (SG). Patients were evaluated preoperatively, and postoperative follow-up was performed at 3, 6, and 12 months. The postoperative evaluation included blood samples for full blood count (FBC), including measure of mean platelet volume (MPV). RESULTS: At the 12-month follow-up, the reduction in preoperative weight was 29 ± 9 %. We showed a significant decrease in platelet count (245 ± 62 vs. 234 ± 54 G/L; p = 0.0015) found in parallel with a non-significant decrease in MPV (9.27 ± 1.1 vs. 9.22 ± 1.05; p = 0.34). With regard to the intervention type, SG caused a more significant decrease in platelet count than RYGBP (p = 0.02). There was no significant difference in MPV variations between the two groups (p = 0.08). CONCLUSIONS: Our results suggest that BS has a positive impact on platelet metabolism, possibly mediated by weight loss. These data need to be confirmed to understand the multifactorial benefits of BS on cardiovascular risk in obesepatients.
Authors: Hisham S Elbatarny; Stuart J Netherton; Jeffrey D Ovens; Alastair V Ferguson; Donald H Maurice Journal: Eur J Pharmacol Date: 2006-12-01 Impact factor: 4.432
Authors: Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Leonelo Bautista; Maria Grazia Franzosi; Patrick Commerford; Chim C Lang; Zvonko Rumboldt; Churchill L Onen; Liu Lisheng; Supachai Tanomsup; Paul Wangai; Fahad Razak; Arya M Sharma; Sonia S Anand Journal: Lancet Date: 2005-11-05 Impact factor: 79.321
Authors: Vicky Cheng; Sangeeta R Kashyap; Philip R Schauer; John P Kirwan; Keith R McCrae Journal: Surg Obes Relat Dis Date: 2011-10-14 Impact factor: 4.734
Authors: Sasidhar Guthikonda; Carlos L Alviar; Muthiah Vaduganathan; Mehmet Arikan; Armando Tellez; Timothy DeLao; Juan F Granada; Jing-Fei Dong; Neal S Kleiman; Eli I Lev Journal: J Am Coll Cardiol Date: 2008-08-26 Impact factor: 24.094
Authors: Ligen Lin; Jong Han Lee; Eric D Buras; Kaijiang Yu; Ruitao Wang; C Wayne Smith; Huaizhu Wu; David Sheikh-Hamad; Yuxiang Sun Journal: Aging (Albany NY) Date: 2016-01 Impact factor: 5.682
Authors: María N Barrachina; Luis A Morán; Irene Izquierdo; Felipe F Casanueva; María Pardo; Ángel García Journal: Sci Rep Date: 2020-08-04 Impact factor: 4.379
Authors: Denis Seyres; Alessandra Cabassi; John J Lambourne; Frances Burden; Samantha Farrow; Harriet McKinney; Joana Batista; Carly Kempster; Maik Pietzner; Oliver Slingsby; Thong Huy Cao; Paulene A Quinn; Luca Stefanucci; Matthew C Sims; Karola Rehnstrom; Claire L Adams; Amy Frary; Bekir Ergüener; Roman Kreuzhuber; Gabriele Mocciaro; Simona D'Amore; Albert Koulman; Luigi Grassi; Julian L Griffin; Leong Loke Ng; Adrian Park; David B Savage; Claudia Langenberg; Christoph Bock; Kate Downes; Nicholas J Wareham; Michael Allison; Michele Vacca; Paul D W Kirk; Mattia Frontini Journal: Clin Epigenetics Date: 2022-03-12 Impact factor: 6.551